Irisin a Novel Metabolic Biomarker: Present Knowledge and Future Directions

Area of Science:

• Metabolic Homeostasis
• Endocrinology
• Exercise Physiology

Background:

• Rising chronic diseases like type 2 diabetes and cardiovascular disease are linked to excess fat mass.
• Muscle-derived irisin (a myokine) is emerging as a key factor in metabolic regulation.
• Irisin's role in adipose tissue browning and thermogenesis is a significant area of research.

Purpose of the Study:

• To review recent findings on irisin, a myokine produced by the fibronectin type III domain containing 5 (FNDC5) gene.
• To explore irisin's potential roles in glucose homeostasis and its association with obesity and type 2 diabetes.
• To discuss novel research directions and potential inter-organ interactions involving irisin.

Main Methods:

• Literature review of recent studies on irisin.
• Analysis of the FNDC5 gene and its protein product, irisin.
• Exploration of irisin's effects on adipose tissue and metabolic pathways.

Main Results:

• Irisin promotes the browning of white adipose tissue into brown adipose tissue, increasing thermogenesis.
• Irisin may play a crucial role in maintaining glucose homeostasis.
• Emerging evidence suggests irisin interacts with organs like the brain and bone.

Conclusions:

• Irisin is a promising myokine with potential therapeutic applications for metabolic diseases.
• Further research into irisin's mechanisms and inter-organ effects is warranted.
• Understanding irisin's role could provide new insights into managing obesity and type 2 diabetes.